These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 33168538)

  • 1. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.
    Edwards K; Allison M; Ghuman S
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary cast formation with sclerosing cholangitis in critically ill patient: case report and literature review.
    Kwon ON; Cho SH; Park CK; Mun SH
    Korean J Radiol; 2012; 13(3):358-62. PubMed ID: 22563276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Acute Pancreatitis in a Patient with COVID-19 Infection.
    Cheung S; Delgado Fuentes A; Fetterman AD
    Am J Case Rep; 2020 Aug; 21():e927076. PubMed ID: 32833954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic.
    Morão B; Revés JB; Nascimento C; Loureiro R; Glória L; Palmela C
    GE Port J Gastroenterol; 2022 Mar; 27(Suppl 2):1-6. PubMed ID: 35528723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients.
    Frithiof R; Bergqvist A; Järhult JD; Lipcsey M; Hultström M
    Crit Care; 2020 Sep; 24(1):587. PubMed ID: 32993742
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID-19 Cholangiopathy: A Novel Entity.
    Roth NC; Kim A; Vitkovski T; Xia J; Ramirez G; Bernstein D; Crawford JM
    Am J Gastroenterol; 2021 May; 116(5):1077-1082. PubMed ID: 33464757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal insufficiency in coronavirus disease 2019: a case report.
    Heidarpour M; Vakhshoori M; Abbasi S; Shafie D; Rezaei N
    J Med Case Rep; 2020 Aug; 14(1):134. PubMed ID: 32838801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.
    Gotthardt D; Stiehl A
    Clin Liver Dis; 2010 May; 14(2):349-58. PubMed ID: 20682240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
    Stripp TK; Søndergaard J
    Ugeskr Laeger; 2020 Apr; 182(16):. PubMed ID: 32286214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRCP versus ERCP in the diagnosis of primary sclerosing cholangitis.
    Thomson A
    Gastrointest Endosc; 2007 Mar; 65(3):558; author reply 558. PubMed ID: 17321274
    [No Abstract]   [Full Text] [Related]  

  • 12. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Fulminant Liver Failure in a 24-Year-Old Man with Coinfection with Hepatitis B Virus and SARS-CoV-2.
    Ali E; Ziglam H; Kohla S; Ahmed M; Yassin M
    Am J Case Rep; 2020 Oct; 21():e925932. PubMed ID: 33046686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Prednisone for Treatment of Autoimmune Pancreatitis in a Patient with Coronavirus Disease 2019 (COVID-19) due to Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Liaquat H; Shupp B; Kapoor S; Matin A
    Am J Case Rep; 2020 Jul; 21():e926475. PubMed ID: 32692733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report.
    Shawkat A; Merrell ET; Fadel GA; Amzuta I; Amin H; Shah AJ; Habeb H; Aiash H
    Am J Case Rep; 2020 Jul; 21():e925786. PubMed ID: 32694498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Kidney Disease: Update on Epidemiology, Clinical Manifestations, Pathophysiology and Management.
    Asgharpour M; Zare E; Mubarak M; Alirezaei A
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):19-25. PubMed ID: 32723443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings.
    Elsayes KM; Oliveira EP; Narra VR; Abou El Abbass HA; Ahmed MI; Tongdee R; Brown JJ
    J Comput Assist Tomogr; 2006; 30(3):398-404. PubMed ID: 16778613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
    Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.